Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a09fa84c54c24536575f7f12c1f1db43 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-14122 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-015 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-35 |
filingDate |
1991-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d68eabb7e97ce257dad16d8e435ab63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_321dd4e526536e61e9ae5b1994d36690 |
publicationDate |
1992-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-0486917-A2 |
titleOfInvention |
Antiviral activity from the rep gene of adenoassociated virus-2 |
abstract |
The invention relates to the use of a rep gene derived from the adeno-associated virus type 2 and having antiviral activity against the HIV-1 virus. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6146847-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0733122-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0733122-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9820146-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9820146-A2 |
priorityDate |
1990-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |